menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Report Library
  • News Media
    • United States
    • United Kingdom
    • Asia Pacific
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Report Library
  • News Media
    • United States
    • United Kingdom
    • Asia Pacific
  • Who Trust Us
  • Datafeature
Home ➤ Companies ➤ Merck KGaA Company Profile

Merck KGaA Company Profile

logo

Merck KGaA

Chemical

  • Type

    Public

  • Headquarters

    Germany

  • Founded

    1668

  • Key Management

    Ms. Belén Garijo(CEO)

  • Revenue

    ~20,820.8 2021)

  • Headcountz

    ~60,348(2021)

  • Website

    www.merckgroup.com

Business Description

Merck KGaA, a science-technology company, is involved in the production of chemical and pharmaceutical products. It operates in the following areas: Healthcare, Life Science and Performance Materials, Corporate, and Others. The Healthcare sector develops and manufactures prescription drugs that treat multiple sclerosis, cancer, and infertility. Life Science provides laboratory materials, technologies, and services to scientists. The Performance Materials sector provides specialty chemicals and materials for difficult applications.

The company offers services in pharma and biopharma manufacturing, pharmaceutical quality control, pharmaceutical research, and government research services. Friedrich Jacob Merck founded the company and it is headquartered in Darmstadt (Germany). Merck Group is home to approximately 250 companies across 180 countries. The current main parent company is Merck KGaA. It is primarily owned by E. Merck oHG which is now a holding company. The company also offers DNA and RNA Extraction Kits through subsidiaries like Sigma-Aldrich and Merck Millipore.

Key Financials

Revenue (US$ Mn):

  • At a -3.32% decrease from , Merck KGaA’s annual revenue of US$ 20,821 Mn was indexed in 2021
  • Merck KGaA generated total revenue of US$ 21,536 Mn in 2020

 

Operating Income (US$ Mn):

  • At a 28.05% increase from , Merck KGaA’s operating income of US$ 4,420 Mn was indexed in 2021
  • Merck KGaA generated an operating income of US$ 3,451 Mn in 2020

 

Net Income (US$ Mn):

  • At a 32.39% increase from , Merck KGaA’s net income of US$ 3,231 Mn was indexed in 2021
  • Merck KGaA generated a net income of US$ 2,441 Mn in 2020

 

Operating Margin %:

  • At a 32.5% increase from , Merck KGaA’s operating margin of 21% was indexed in 2021
  • Merck KGaA generated an operating margin of 16% in 2020

 

Gross Margin %:

  • At a 37.17% increase from , Merck KGaA’s gross margin of 16% was indexed in 2021
  • Merck KGaA generated a gross margin of 11% in 2020

SWOT Analysis

Strengths:

Growth in revenue

The company reported steady revenue growth during the review year. Strong financial performance improves investors’ confidence in the company and enables it to pursue expansion plans. In FY2020, the company reported revenue of EUR17,534 million as compared to EUR16,152 million in FY2019, an annual growth of 8.6%. Growth in the revenue was due to an increase in revenue from Life Science, and Performance Materials segments by 9.5%, and 31.3%, respectively.

Get this premium content

The Premium data is Locked
Buy Now to Unlock Premium Data

Table of Content

  1. Business Description
  2. Key Financials
  3. SWOT Analysis
    1. Strength
      1. Growth in revenue
      2. Strong R&D capabilities
      3. Global footprint
    2. Weaknesses
      1. Litigations
    3. Opportunities
      1. Inorganic growth strategy
      2. Positive outlook for global pharmaceutical industry provides growth opportunity for the company
      3. Strategic acquisitions
    4. Threats
      1. Negative political and macroeconomic developments
      2. Healthcare cost containment measures
      3. Time-consuming and expensive development process
    5. Key Developments
      1. Year 2022
      2. Year 2021
      3. Year 2020
  • US $299
  • US $499
Buy Now
✖

Request For Company Data

We'll get back to you as quickly as possible

Primary Sidebar

  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo

Find Help

  • Contact Us
  • How to Order

Legal

  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions

Explore

  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

Secured Payment Options

Secured Payment Options

© 2023 Market.Us. All Rights Reserved.